These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16326416)

  • 21. Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors.
    De Caro E; Smeraldi A; Trocchio G; Calevo M; Hanau G; Pongiglione G
    Pediatr Blood Cancer; 2011 Jan; 56(1):122-6. PubMed ID: 21058389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.
    Oztarhan K; Guler S; Aktas B; Arslan M; Salcioglu Z; Aydogan G
    Pediatr Hematol Oncol; 2011 Aug; 28(5):380-94. PubMed ID: 21699467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of systolic and diastolic function of the left ventricle in children with acute lymphoblastic leukaemia before treatment].
    Jackowska T; Pleskot M; Gołabek M; Rokicka-Milewska R; Wróblewska-Kałuzewska M; Wypych A; Matysiak M; Klus K; Juraszewska E; Balwierz W; Wójcik B; Sadurska E; Kowalczyk J; Stencel D; Siwinska A; Wachowiak J; Szmyd K; Kukawczyńska E; Chybicka A; Płoszyńska A; Aleszewicz-Baranowska J; Balcerska A; Ostański M; Pobudejska A; Sońta-Jakimczyk D; Krenke K; Madry W; Syczewska M; Rudziński A
    Przegl Lek; 2004; 61 Suppl 2():70-5. PubMed ID: 15686051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy.
    Hashimoto I; Ichida F; Miura M; Okabe T; Kanegane H; Uese K; Hamamichi Y; Misaki T; Koizumi S; Miyawaki T
    Circulation; 1999 May; 99(18):2367-70. PubMed ID: 10318655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echocardiographic evaluation of systolic and diastolic left ventricular function following arterial switch operation in the neonatal period for transposition of the great arteries. Midterm results.
    Crepaz R; Secchieri S; Svaluto G; Milanesi O; Pitscheider W; Gentili L; Rubino M; Stellin G
    G Ital Cardiol; 1997 Mar; 27(3):224-30. PubMed ID: 9199950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H
    Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.
    Serrano JM; González I; Del Castillo S; Muñiz J; Morales LJ; Moreno F; Jiménez R; Cristóbal C; Graupner C; Talavera P; Curcio A; Martínez P; Guerra JA; Alonso JJ
    Oncologist; 2015 Aug; 20(8):864-72. PubMed ID: 26185196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines: a longitudinal, prospective exercise echocardiography study.
    Guimaraes-Filho FV; Tan DM; Braga JC; Rodrigues A; Waib PH; Matsubara BB
    Pediatr Blood Cancer; 2012 Sep; 59(3):548-52. PubMed ID: 22970439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthracycline chemotherapy impairs the structure and diastolic function of the left ventricle and induces negative arterial remodelling.
    Mizia-Stec K; Gościńska A; Mizia M; Haberka M; Chmiel A; Poborski W; Gąsior Z
    Kardiol Pol; 2013; 71(7):681-90. PubMed ID: 23907900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Left Ventricular Diastolic Function in Patients with Diffuse Large B-cell Lymphoma after Anthracycline Chemotherapy by using Vector Flow Mapping.
    Yang K; Hu J; Yuan X; Xiahou Y; Ren P
    Curr Med Imaging; 2024; 20():e15734056298648. PubMed ID: 38874029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
    Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
    Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function.
    Dorup I; Levitt G; Sullivan I; Sorensen K
    Heart; 2004 Oct; 90(10):1214-6. PubMed ID: 15367528
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments.
    de Ville de Goyet M; Brichard B; Robert A; Renard L; Veyckemans F; Vanhoutte L; Moniotte S
    Pediatr Blood Cancer; 2015 May; 62(5):867-74. PubMed ID: 25597617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
    Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal-averaged electrocardiography in children with anthracycline-induced cardiomyopathy.
    Vaksmann G; Gutierrez R; Duhamel A; Nelken B; Francart C; Kouakam C; Mazingue F; Rey C
    Pediatr Cardiol; 2001; 22(6):494-8. PubMed ID: 11894153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors.
    De Wolf D; Suys B; Maurus R; Benoit Y; Verhaaren H; Matthijs D; Otten J
    Pediatr Res; 1996 Mar; 39(3):504-12. PubMed ID: 8929873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
    Ylänen K; Poutanen T; Savikurki-Heikkilä P; Rinta-Kiikka I; Eerola A; Vettenranta K
    J Am Coll Cardiol; 2013 Apr; 61(14):1539-47. PubMed ID: 23500246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
    Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A
    J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.
    Kapusta L; Groot-Loonen J; Thijssen JM; DeGraaf R; Daniëls O
    Med Pediatr Oncol; 2003 Nov; 41(5):426-35. PubMed ID: 14515381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.